Allarity Therapeutics

ALLRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$21.490 M

$1.39 -0.71%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$11.2M

Loss-making

Shares outstanding

15,818,980

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#389Tvardi TherapeuticsTVRD$23.3M
#390Quantum BiopharmaQNTM$22.1M
#391Allarity TherapeuticsALLR$21.5M
#392CalciMedicaCALC$21.1M
#393NextCureNXTC$21.1M

Where these numbers come from

Share counts and financials for Allarity Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.